ADMA Biologics ADMA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.33M-8.2% | $49.38M+35.6% | $36.43M+6.5% | $34.22M+27.2% | $26.9M-76.0% | ||
| $1.8M-10.0% | $2M0.0% | $2M0.0% | $2M+5.3% | $1.9M-5.0% | ||
| $6.33M+17.4% | $5.39M+6.8% | $5.05M+1.7% | $4.96M+7.3% | $4.62M-14.9% | ||
| $3.29M+181% | $1.17M-75.6% | $4.8M+196% | $1.62M-52.7% | $3.43M+104% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $8M+88,989% | -$9K— | $0— | $0— | $0+100% | ||
| -$22.57M-209% | $20.76M-25.7% | $27.95M+171% | $10.31M-79.1% | $49.41M— | ||
| $15.63M+59.6% | $9.8M+88.3% | $5.2M-73.0% | $19.28M+887% | $1.95M+225% | ||
| -$1.23M— | —— | —— | $9.27M+6,426% | $142K-96.4% | ||
| $5.11M-52.0% | $10.64M+4,914% | -$221K+92.1% | -$2.81M-16.8% | -$2.4M-137% | ||
| $1.6M+193% | $547K— | —— | —— | $2.6M— | ||
| -$340K+13.9% | -$395K-68.8% | -$234K— | $0+100% | -$650K-121% | ||
| —— | 0.3%— | —— | —— | —— | ||
| $55K+7.8% | $51K+34.2% | $38K+18.8% | $32K+28.0% | $25K0.0% | ||
| $191K-3.0% | $197K+15.9% | $170K+6.3% | $160K-15.8% | $190K-13.2% | ||
| $58.25M+63.4% | $35.64M+168% | $13.29M-37.1% | $21.14M+207% | -$19.68M-139% | ||
| $2.54M+135% | $1.08M-92.5% | $14.37M+493% | $2.42M-48.5% | $4.7M+70.5% | ||
| $53K-72.4% | $192K— | $0-100% | $105K+453% | $19K— | ||
| $2.6M+88.7% | $1.38M-9.9% | $1.53M+48.2% | $1.03M+24.8% | $826K+111% | ||
| $2.4M+971% | -$276K+98.1% | -$14.37M-469% | -$2.53M+46.5% | -$4.72M-71.6% | ||
| $130.19M+1,362% | $8.9M— | —— | —— | $0— | ||
| $588K+36.7% | $430K+10.5% | $389K-81.2% | $2.06M+1,944% | $101K+101% | ||
| -$10.13M-11.1% | -$9.12M+67.2% | -$27.83M— | $0+100% | -$7.13M+77.0% | ||
| $50.52M— | —— | -$28.9M— | —— | -$31.52M-292% | ||
| $1.33M-2.6% | $1.36M-50.7% | $2.76M+25.1% | $2.21M-19.7% | $2.75M-15.4% | ||
| $91K-98.3% | $5.34M-28.4% | $7.46M+8.2% | $6.89M— | $0-100% | ||
| $191K-3.0% | $197K+15.9% | $170K+6.3% | $160K-15.8% | $190K-13.2% | ||
| -$36K0.0% | -$36K0.0% | -$36K-2.9% | -$35K+2.8% | -$36K0.0% | ||
| -$42K-367% | -$9K— | $0— | $0— | $0+100% | ||
| $8M— | —— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | -$2.76M0.0% | -$2.76M0.0% | -$2.76M0.0% | -$2.76M-113% | ||
| -$379K+29.8% | -$540K-1,100% | -$45K-111% | $426K+455% | -$120K+71.8% | ||
| $1.6M+193% | $547K— | —— | —— | $2.6M— | ||
| —— | —— | —— | —— | —— | ||
| $45.33M— | —— | $36.43M+6.5% | $34.22M+27.2% | $26.9M— | ||
| —— | —— | —— | —— | $400K— | ||
| $53K-72.4% | $192K— | $0-100% | $105K+453% | $19K— | ||
| $5M— | —— | —— | —— | $0— | ||
| $5.06M+2,984% | $164K-83.0% | $964K-19.1% | $1.19M-83.5% | $7.23M+1,022% | ||
| —— | —— | —— | —— | —— | ||
| $33.74M-33.0% | $50.35M-14.1% | $58.6M+7.0% | $54.76M+2.0% | $53.71M-0.9% | ||
| $80.75M-9.1% | $88.82M+17.4% | $75.63M+12.5% | $67.23M+10.0% | $61.1M-3.5% | ||
| $57.13M-7.3% | $61.6M+29.6% | $47.52M+18.5% | $40.1M+19.9% | $33.45M-3.6% | ||
| —— | $470.75K0.0% | $470.75K0.0% | $470.75K0.0% | $470.75K— | ||
| $2.1M+29.2% | $1.63M-2.9% | $1.68M-8.7% | $1.83M-7.1% | $1.98M-31.4% | ||
| —— | $775K0.0% | $775K0.0% | $775K0.0% | $775K+14.8% | ||
| -$1.15M+0.8% | -$1.16M+66.9% | -$3.5M-29.5% | -$2.7M-88.7% | -$1.43M+60.4% | ||
| $1.06M-5.7% | $1.13M-11.5% | $1.27M+10.4% | $1.15M-10.4% | $1.29M+0.7% | ||
| $700K— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $523.25K0.0% | $523.25K0.0% | $523.25K0.0% | $523.25K— | ||
| —— | $4.92M0.0% | $4.92M0.0% | $4.92M0.0% | $4.92M— | ||
| $55.71M+61.2% | $34.56M+3,314% | -$1.08M-106% | $18.72M+177% | -$24.38M-151% | ||
| $55.71M+61.2% | $34.56M+3,314% | -$1.08M-106% | $18.72M+177% | -$24.38M-151% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does ADMA Biologics's cash flow data come from?
- Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.